$NTVA NEXIEN BIOPHARMA, INC. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEXIEN BIOPHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NEXIEN BIOPHARMA, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in NEXIEN BIOPHARMA, INC. for free.
IRS Number: 262049376
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: NTVA
Company Address: 4340 E KENTUCKY AVE SUITE 206 GLENDALE 80246
Phone number: 3034957583
Former name: Kinder Holding Corp., date of change: 2014-11-14
Former name: Intiva BioPharma Inc., date of change: 2017-11-29
Market Capitalization: $240726.00
Prev close: $0.01
Average Daily Volume: 30,727
Days Low: $0.01
Year Low: $0.00
Year High: $0.90
NEXIEN BIOPHARMA, INC. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 05 2021 | NTVA | NEXIEN BIOPHARMA, ... | Wasoff Evan L | Chief Financial Off ... | Grant | A | 0.00 | 1,000,000 | 0 | 2,000,000 | 1000 K to 2 M (+100.00 %) |
| Apr 05 2021 | NTVA | NEXIEN BIOPHARMA, ... | Greenberg Richard S | Chief Executive Off ... | Grant | A | 0.00 | 1,000,000 | 0 | 3,685,192 | 2.7 M to 3.7 M (+37.24 %) |
| Nov 30 2020 | NTVA | NEXIEN BIOPHARMA, ... | Greenberg Richard S | Chief Executive Off ... | Option Exercise | A | 0.05 | 1,062,953 | 48,045 | 1,062,953 | |
| Nov 30 2020 | NTVA | NEXIEN BIOPHARMA, ... | Greenberg Richard S | Chief Executive Off ... | Option Exercise | A | 0.04 | 1,062,953 | 46,026 | 1,062,953 | |
| Nov 30 2020 | NTVA | NEXIEN BIOPHARMA, ... | Greenberg Richard S | Chief Executive Off ... | Option Exercise | A | 0.04 | 1,062,953 | 42,837 | 1,062,953 | |
| Aug 21 2020 | NTVA | NEXIEN BIOPHARMA, ... | Greenberg Richard S | Chief Executive Off ... | Option Exercise | A | 0.08 | 2,500,000 | 200,000 | 2,500,000 | |
| Aug 21 2020 | NTVA | NEXIEN BIOPHARMA, ... | Wasoff Evan L | Chief Financial Off ... | Option Exercise | A | 0.08 | 1,500,000 | 120,000 | 1,500,000 | |
| Aug 21 2020 | NTVA | NEXIEN BIOPHARMA, ... | Goldfarb Robert I | Chief Operating Off ... | Option Exercise | A | 0.08 | 1,000,000 | 80,000 | 1,000,000 | |
| Aug 14 2020 | NTVA | NEXIEN BIOPHARMA, ... | Greenberg Richard S | Chief Executive Off ... | Buy | C | 0.01 | 1,800,880 | 25,212 | 2,688,880 | 888 K to 2.7 M (+202.80 %) |
| Nov 25 2019 | NTVA | NEXIEN BIOPHARMA, ... | Friedland Jeffrey | Gift | G | 0.00 | 228,800 | 0 | 0 | 228.8 K to 0 (-100.00 %) | |
| Nov 25 2019 | NTVA | NEXIEN BIOPHARMA, ... | Friedland Jeffrey | Gift | G | 0.00 | 833,333 | 0 | 0 | 833.3 K to 0 (-100.00 %) | |
| May 02 2019 | NTVA | NEXIEN BIOPHARMA, ... | Kanativa Inc. | 10% Owner | Sell | S | 0.09 | 5,000,000 | 425,000 | 19,000,000 | 24 M to 19 M (-20.83 %) |
| May 01 2019 | NTVA | NEXIEN BIOPHARMA, ... | Kanativa USA Inc. | 10% Owner | Sell | S | 0.09 | 5,000,000 | 425,000 | 19,000,000 | 24 M to 19 M (-20.83 %) |
| May 01 2019 | NTVA | NEXIEN BIOPHARMA, ... | Friedland Jeffrey | Sell | S | 0.09 | 5,000,000 | 425,000 | 19,000,000 | 24 M to 19 M (-20.83 %) | |
| Oct 30 2018 | NTVA | NEXIEN BIOPHARMA, ... | Wasoff Evan L | Chief Financial Off ... | Option Exercise | A | 0.66 | 200,000 | 131,000 | 200,000 |